Newsletter | April 18, 2025

04.18.25 -- Stage 3a: The Pinnacle Of Process Validation Advancement

INDUSTRY INSIGHTS

Fundamentals Of Power Blending Simulations

Predicting blending quality doesn't have to be a guessing game. Learn how to leverage virtual prototypes to make informed decisions and minimize costly trial-and-error in tablet manufacturing.

Early Network Mapping To Guide HTA Literature Reviews

How do we identify the right evidence efficiently? Early network mapping can help manufacturers balance a focused scope with the need to conduct indirect treatment comparisons.

Solutions For Overcoming Scalability Challenges In CGT Manufacturing

Advanced therapies present challenges when it comes to scaling up production. Explore how collaboration, investment in R&D, and process optimization are paving the way for new treatments.

Delving Into Modular Cleanroom Designs For Drug Manufacturing

Uncover the reasoning behind the increasing demand for cleanroom technology as well as the advantages modular cleanroom design brings to the sterile processing of complex therapies.

Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion

Discover a screening process to quickly assess HME feasibility that yields more accurate predictions for API loading and degradation while saving material and time compared to traditional approaches.

The Impact Of The FDA's New CSA Draft Guideline

Ensure product quality and patient safety by examining the FDA's draft guideline on Computer Software Assurance that emphasizes a risk-based approach to streamline software validation.

Nanoformed API: A Superior Alternative To Solid Dispersions

Cutting-edge nanotechnology is now emerging, able to address bioavailability challenges and deliver higher drug loads in more patient-friendly formats with fewer and smaller pills and easier regimens.

Observations That Can Be Avoided With The Right Software Partner

FDA 483 findings frequently cite a lack of data integrity, process adherence, and quality control. Find out why these issues persist and the significant risks they pose to pharmaceutical manufacturers today.

The Importance Of Flexibility In HPAPI Small-Batch Manufacturing

Watch as experts provide insight into the challenges of HPAPI manufacturing and offer proven strategies for achieving the flexibility required for small-batch production.

A Cost-Effective Alternative To Traditional Protein A Resin Chromatography

Examine this cost-effective, efficient alternative to traditional Protein A resin chromatography for mAb production to enhance productivity and reduce costs.

The Future Is Now: How AI Is Reshaping Life Sciences

Artificial Intelligence (AI) is becoming more prevalent today and will play a crucial role in the future. Review the latest AI trends revolutionizing quality management systems in life sciences.

FEATURED EDITORIAL

Stage 3a: The Pinnacle Of Process Validation Advancement

Process validation's stage 3a serves to reconfirm the assumptions made during design space development and is particularly pronounced for new modalities and emerging processes.

SOLUTIONS

Comprehensive GMP Testing Services

Capacity Update January 2025: Small Molecule

Bio-Expo Live 2024: Quality, Data, & Analytical Solutions

Leveraging Proprietary CDO Platforms

Enhance Your Aseptic Fill-Finish Efficiency

A Leading Digital Validation Platform For Life Sciences

Primary Drug Containers

Connect With Pharmaceutical Online: